LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

NCT01257477 · clinicaltrials.gov ↗
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Prometheus Laboratories